Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Misuse of Drugs Act 1971 (Modification) Order 1989

As Enacted Cited in Amendments 3 Related
Vincent
JurisdictionUK Non-devolved
CitationSI 1989/1340

1989 No. 1340

DANGEROUS DRUGS

The Misuse of Drugs Act 1971 (Modification) Order 1989

2ndAugust 1989

18thSeptember 1989

At the Court at Buckingham Palace, the 2nd day of August 1989

Present,

The Queen's Most Excellent Majesty in Council

Whereas a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and has been approved by a resolution of each House of Parliament:

Now, therefore, Her Majesty, in pursuance of section 2(2) of the Misuse of Drugs Act 1971 (a) , is pleased, by and with the advice of Her Privy Council, to order, and it is hereby ordered, as follows:

1. This Order may be cited as the Misuse of Drugs Act 1971 (Modification) Order 1989 and shall come into force on 18th September 1989.

2. Schedule 2 to the Misuse of Drugs Act 1971 (which, as amended (b) , specifies the drugs which are subject to control under that Act) shall be amended by the insertion in paragraph 1 of Part III of that Schedule-

(a) after the word "Bromazepam" , of the word "Buprenorphine" , and(b) after the word "Oxazolam" , of the word "Pemoline" .

G. I. de Deney

Clerk of the Privy Council
(a) 1971 c.38.
(b) S.I. 1973/771, 1975/421, 1977/1243, 1979/299, 1983/765, 1984/859, 1985/1995, 1986/2230.

EXPLANATORY NOTE

(This note is not part of the Order)

This Order adds to Part III of Schedule 2 to the Misuse of Drugs Act 1971 (which specifies the Class C drugs which are subject to control under the Act) Buprenorphine and Pemoline.

ISBN 0 11 097340 2

Enabling power: Misuse of Drugs Act 1971, s. 2 (2).

Effect: Act 1971, c.38 amended.

Issued:

[10 9 89]

Territorial extent and classification: E/W/S/NI. General..

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT